PMC:7696151 / 24352-24550 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"704","span":{"begin":57,"end":64},"obj":"Species"},{"id":"718","span":{"begin":152,"end":155},"obj":"Chemical"},{"id":"728","span":{"begin":80,"end":119},"obj":"Disease"}],"attributes":[{"id":"A704","pred":"tao:has_database_id","subj":"704","obj":"Tax:9606"},{"id":"A718","pred":"tao:has_database_id","subj":"718","obj":"MESH:D006886"},{"id":"A728","pred":"tao:has_database_id","subj":"728","obj":"MESH:D017119"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"results were confirmed by several case reports regarding patient treatment with Porphyria Cutanea Tarda and Hepatitis C. It was seen that a low dose of HCQ (100 mg twice weekly) prevented the recurr"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T33","span":{"begin":108,"end":117},"obj":"Phenotype"}],"attributes":[{"id":"A33","pred":"hp_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"results were confirmed by several case reports regarding patient treatment with Porphyria Cutanea Tarda and Hepatitis C. It was seen that a low dose of HCQ (100 mg twice weekly) prevented the recurr"}